{"id":175146,"date":"2025-01-21T22:11:53","date_gmt":"2025-01-21T22:11:53","guid":{"rendered":"https:\/\/globetimeline.com\/ar\/tech\/rewrite-this-title-in-arabic-ai-developed-drug-will-be-in-trials-by-year-end-says-googles-hassabis\/"},"modified":"2025-01-21T22:11:53","modified_gmt":"2025-01-21T22:11:53","slug":"rewrite-this-title-in-arabic-ai-developed-drug-will-be-in-trials-by-year-end-says-googles-hassabis","status":"publish","type":"post","link":"https:\/\/globetimeline.com\/ar\/tech\/rewrite-this-title-in-arabic-ai-developed-drug-will-be-in-trials-by-year-end-says-googles-hassabis\/","title":{"rendered":"rewrite this title in Arabic AI-developed drug will be in trials by year-end, says Google\u2019s Hassabis"},"content":{"rendered":"<p>Summarize this content to 2000 words in 6 paragraphs in Arabic Stay informed with free updatesSimply sign up to the Artificial intelligence myFT Digest &#8212; delivered directly to your inbox.Isomorphic Labs, the four-year old drug discovery start-up owned by Google parent Alphabet, will have an artificial intelligence-designed drug in trials by the end of this year, says its founder Sir Demis Hassabis.\u201cWe\u2019re looking at oncology, cardiovascular, neurodegeneration, all the big disease areas, and I think by the end of this year, we\u2019ll have our first drug,\u201d he said in an interview with the Financial Times at the World Economic Forum.\u201cIt usually takes an average of five to 10 years [to discover] one drug. And maybe we could accelerate that 10 times, which would be an incredible revolution in human health,\u201d said Hassabis, who received the Nobel Prize for chemistry with his colleague John Jumper and biochemist David Baker in October.Isomorphic was spun out of Google\u2019s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up\u2019s potential has attracted big pharmaceutical partners, which are keen to lower expenses and boost efficiency of the costly drug development process.Hassabis previously told the FT his team was working on six drug development programmes with Eli Lilly and Novartis.In a wide-ranging interview, Hassabis, who is also chief executive of Google DeepMind, said the search giant\u2019s prototype of an AI assistant, known as Project Astra, will probably roll out to consumers later this year. He described a near future, within three years, when there are \u201cbillions\u201d of AI agents, \u201cnegotiating with each other on behalf of the vendor and the customer\u201d and said it would require a rethinking of the web itself.He also called for more caution and co-ordination among leading AI developers competing to build artificial general intelligence. He warned the technology could threaten human civilisation if it runs out of control or is repurposed by \u201cbad actors\u2009.\u2009.\u2009.\u2009for harmful ends\u201d.Google DeepMind\u2019s ultimate goal is to create artificial general intelligence, or \u201ca system that is capable of exhibiting all the cognitive capabilities that humans have\u201d, according to Hassabis, who said that despite social media \u201chype\u201d about it being close, true AGI was still five to 10 years away.\u201cIf something\u2019s possible and valuable to do, people will do it,\u201d Hassabis said. \u201cWe\u2019re past that point now with AI, the genie can\u2019t be put back in the bottle\u2009.\u2009.\u2009.\u2009so we have to try and make sure to steward that into the world in as safe a way as possible.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Summarize this content to 2000 words in 6 paragraphs in Arabic Stay informed with free updatesSimply sign up to the Artificial intelligence myFT Digest &#8212; delivered directly to your inbox.Isomorphic Labs, the four-year old drug discovery start-up owned by Google parent Alphabet, will have an artificial intelligence-designed drug in trials by the end of this<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63],"tags":[],"class_list":{"0":"post-175146","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-tech"},"_links":{"self":[{"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/posts\/175146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/comments?post=175146"}],"version-history":[{"count":0,"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/posts\/175146\/revisions"}],"wp:attachment":[{"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/media?parent=175146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/categories?post=175146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/globetimeline.com\/ar\/wp-json\/wp\/v2\/tags?post=175146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}